RRAGA and cancer: The GATOR1 complex, which consists of DEPDC5, Nprl2 and Nprl3, has GAP activity for RagA/B, and its inactivating mutations in cancers result in mTORC1 hyperactivation (Bar-Peled et al., 2013).